Condition: Human Papillomavirus (HPV) · Cervical Intraepithelial Neoplasia · Uterine Cervical Neoplasms · Sponsor: DL Analytics
The purpose of this study is to validate Automated Visual Evaluation (AVE), specifically the CINFinder version developed by DL Analytics, a point-of-care screening and triage diagnostic tool for cervical cancer based on the assessment of digital images through artificial intelligence. Several teams around the world have developed versions of AVE as a triage technology but none as a screening tool.
This description comes directly from the study's public registry record.
David Levitz, PhD · 817-966-5600 · levitz@dlanalytics.ai
Always discuss trial participation with your own doctor first.
| Ministerio de Salud | San Salvador, El Salvador | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06815939